Cargando…
The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK
BACKGROUND: NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnosis and identification of residual disease. We independently assessed utility of the NETest to diagnose gastric neuroendocrine neoplasms (GNENs) and identify micro- and macroscopic residual disease....
Autores principales: | Malczewska, A., Procner, A., Walter, A., Kusnierz, K., Zajecki, W., Aslanian, H., Kos-Kudla, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376918/ https://www.ncbi.nlm.nih.gov/pubmed/32703157 http://dx.doi.org/10.1186/s12876-020-01348-2 |
Ejemplares similares
-
NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
por: Malczewska, Anna, et al.
Publicado: (2019) -
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
por: Malczewska, Anna, et al.
Publicado: (2019) -
Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020) -
NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
por: Malczewska, Anna, et al.
Publicado: (2020) -
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)